News
-
-
PRESS RELEASE
Alzchem Group AG: Annual General Meeting approves 50% dividend increase to EUR 1.80 and re-election of Supervisory Board members
Alzchem Group AG approves 50% dividend increase to EUR 1.80 at Annual General Meeting and re-elects Supervisory Board members. Successful fiscal year 2024 showcased -
-
PRESS RELEASE
Alzchem Group AG continues earnings growth in the first quarter of 2025; projects to expand nitroguanidine capacity launched
Alzchem Group AG achieves earnings growth in Q1 2025 despite lower revenue, plans to expand nitroguanidine capacity. Positive outlook for sales and EBITDA growth in 2025 -
-
-
-
PRESS RELEASE
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Temporary Interruption of Share Repurchase Prog
Alzchem Group AG temporarily interrupts its share repurchase programme in preparation for the Annual Shareholders Meeting on May 8, 2025, to ensure proper shareholder dividend payments -
-
PRESS RELEASE
Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research
Alzchem Group organizes Creatine Conference 2025 in Munich, bringing together creatine experts for discussions on fatigue, women's health, cognitive performance, and more. Event in hybrid format allowing online attendance